Only once investment
Advancement in technology have made it possible to identify genetic variations patient by patient and thereby a potential exists for payors to adopt initiatives to contain cost and increase the value of health care benefits. Personal Medicine Profile analysis must be carried out only once – it is a once only investment.
The test does not have to be repeated as the case we know from e.g., blood samples or X-rays for medical conditions. Without extra costs free updates of new medication with pharmacogenomic guidelines are continuously updated for each report. This means that healthcare personnel will be able use the latest recommendations whenever the patient is re-admitted to the sector.
The integration of pharmacogenomics into clinical practice provides physicians and pharmacists a powerful tool to personalize medical treatment, better manage costs and utilize more value from effective medication management.
Using the right medication early on may shorten the course of illness and make it better to be a patient in the healthcare sector 6.
Can wrong medication cause hospitalisation
In some countries e.g., Denmark, hospitalization due to medication errors is not registered. However, in England and Belgium, it is found that 6.5% – 10% of all hospitalizations are due to medication errors. It is estimated to be at the level of 10% in the Scandinavian countries.
Patients with adverse drug reactions have a longer length of stay at hospital than those without (4 vs 3 days depending on guidelines for hospitalization6)
Recent investigations into adverse drug reaction hospitalization concluded that 30% of adverse drug reactions at admission were caused by at least one drug with Pharmacogenomic guidelines, suggesting many ADRs could have been predicted by Pharmacogenomic testing6